Skip to content

Total debt at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$3.06B+15.6%
Glaukos logo
GlaukosGKOS
$105.87M-1.7%
Warby Parker logo
Warby ParkerWRBY
$237.63M+6.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
AbbVie logo
AbbVieABBV
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Calculated from Bausch + Lomb’s reported figures.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's total debt?
Bausch + Lomb (BLCO) reported total debt of $5.04B in Q1 2026.
How has Bausch + Lomb's total debt changed year-over-year?
Bausch + Lomb's total debt increased by 4.3% year-over-year, from $4.83B to $5.04B.
What is the long-term trend for Bausch + Lomb's total debt?
Over 4 years (2021 to 2025), Bausch + Lomb's total debt has grown at a 161.2% compound annual growth rate (CAGR), from $112M to $5.21B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.